Francis Laura
Chief Executive Officer at SIBN; Director at Shockwave Medical, Inc.
- Sold, on record
- $14.7M
- Dollars the filings state
- Form 4 sales
- 54
- Latest Nov 17, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- SIBNSI-BONE, Inc.Chief Executive Officer
- Shockwave Medical, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- SIBN639,923 shares
- Shockwave Medical, Inc.11,397 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale SIBNRoutineNov 11 2025
Sold 5,411 shares at $17.06 ($92k)
Francis Laura, Chief Executive Officer
10b5-1 planSold 1.5% of holdings ($6.2M position)356,730 shares left0.4x usual sizeFiling
- 2 Form 4 sale SIBNRoutineNov 18 +7 days
Sold 16,752 shares at $17.51 ($293k)
Francis Laura, Chief Executive Officer
10b5-1 planSold 3.9% of holdings ($7.4M position)408,363 shares left1.5x usual sizeFiling
- 3 Form 4 sale SIBNUnusualFeb 17 +91 days
Sold 93,475 shares at $15.32 ($1.4M)
Francis Laura, Chief Executive Officer
No 10b5-1 planSold 14.7% of holdings ($9.8M position)544,369 shares left8.2x usual sizeFiling
- 4 Form 4 sale SIBNNo planMay 18 +90 days
Sold 14,957 shares at $14.71 ($220k)
Francis Laura, Chief Executive Officer
No 10b5-1 planSold 2.9% of holdings ($7.6M position)503,444 shares left1.1x usual sizeFiling
- 5 Form 4 sale SIBNNo planAug 17 +91 days
Sold 14,956 shares at $18.66 ($279k)
Francis Laura, Chief Executive Officer
No 10b5-1 planSold 2.9% of holdings ($9.5M position)493,900 shares left0.9x usual sizeFiling
- 6 Form 4 sale SIBNUnusualAug 21 +4 days
Sold 55,807 shares at $19.50 ($1.1M)
Francis Laura, Chief Executive Officer
10b5-1 planSold 15% of holdings ($7.3M position)317,463 shares left3.7x usual sizeFiling
- 7 Form 4 sale SIBNRoutineAug 24 +3 days
Sold 25,972 shares at $20.12 ($523k)
Francis Laura, Chief Executive Officer
10b5-1 planSold 8.2% of holdings ($6.4M position)291,491 shares left1.6x usual sizeFiling
- 8 Form 4 sale SIBNRoutineNov 17 +85 days
Sold 16,854 shares at $23.31 ($393k)
Francis Laura, Chief Executive Officer
10b5-1 planSold 4.6% of holdings ($8.6M position)351,275 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (55)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | SIBN | Chief Executive Officer | Form 4 sale | 16,854 | $393k | 4.6% | Routine | SEC |
| Aug 24, 2026 | SIBN | Chief Executive Officer | Form 4 sale | 25,972 | $523k | 8.2% | Routine | SEC |
| Aug 21, 2026 | SIBN | Chief Executive Officer | Form 4 sale | 55,807 | $1.1M | 15.0% | Unusual | SEC |
| Aug 17, 2026 | SIBN | Chief Executive Officer | Form 4 sale | 14,956 | $279k | 2.9% | No plan | SEC |
| May 18, 2026 | SIBN | Chief Executive Officer | Form 4 sale | 14,957 | $220k | 2.9% | No plan | SEC |
| Feb 17, 2026 | SIBN | Chief Executive Officer | Form 4 sale | 93,475 | $1.4M | 14.7% | Unusual | SEC |
| Nov 18, 2025 | SIBN | Chief Executive Officer | Form 4 sale | 16,752 | $293k | 3.9% | Routine | SEC |
| Nov 11, 2025 | SIBN | Chief Executive Officer | Form 4 sale | 5,411 | $92k | 1.5% | Routine | SEC |
| Aug 18, 2025 | SIBN | Chief Executive Officer | Form 4 sale | 11,343 | $177k | 2.6% | No plan | SEC |
| Jul 7, 2025 | SIBN | Chief Executive Officer | Form 4 sale | 757 | $14k | 0.2% | Routine | SEC |
| May 19, 2025 | SIBN | Chief Executive Officer | Form 4 sale | 17,797 | $349k | 3.5% | Routine | SEC |
| May 7, 2025 | SIBN | Chief Executive Officer | Form 4 sale | 38,504 | $661k | 11.3% | Unusual | SEC |
| Feb 18, 2025 | SIBN | Chief Executive Officer | Form 4 sale | 46,233 | $796k | 8.4% | Unusual | SEC |
| Nov 18, 2024 | SIBN | Chief Executive Officer | Form 4 sale | 10,048 | $126k | 2.0% | No plan | SEC |
| Aug 16, 2024 | SIBN | Chief Executive Officer | Form 4 sale | 9,967 | $138k | 2.0% | No plan | SEC |
| Mar 26, 2024 | Shockwave Medical, Inc. | Director | Form 4 sale | 1,500 | $450k | 29.7% | Routine | SEC |
| Feb 16, 2024 | SIBN | Chief Executive Officer | Form 4 sale | 38,587 | $809k | 7.1% | Unusual | SEC |
| Feb 16, 2024 | Shockwave Medical, Inc. | Director | Form 4 sale | 1,000 | $250k | 22.0% | No plan | SEC |
| Aug 22, 2023 | Shockwave Medical, Inc. | Director | Form 4 sale | 497 | $110k | 14.0% | Routine | SEC |
| Aug 22, 2023 | Shockwave Medical, Inc. | Director | Form 144 notice | 497 | $109k | Notice | SEC | |
| Aug 16, 2023 | SIBN | Chief Executive Officer | Form 4 sale | 9,012 | $189k | 2.0% | No plan | SEC |
| May 16, 2023 | SIBN | Chief Executive Officer | Form 4 sale | 9,009 | $224k | 2.0% | No plan | SEC |
| Feb 28, 2023 | SIBN | Chief Executive Officer | Form 4 sale | 35,000 | $708k | 7.2% | Unusual | SEC |
| Feb 16, 2023 | SIBN | Chief Executive Officer | Form 4 sale | 13,483 | $226k | 2.9% | Plan not stated | SEC |
| Aug 16, 2022 | SIBN | Chief Executive Officer | Form 4 sale | 5,248 | $91k | 1.6% | Plan not stated | SEC |
| May 16, 2022 | SIBN | Chief Executive Officer | Form 4 sale | 4,805 | $60k | 1.4% | Plan not stated | SEC |
| Mar 31, 2022 | Shockwave Medical, Inc. | Director | Form 4 sale | 4,200 | $848k | 100.0% | Unusual | SEC |
| Feb 16, 2022 | SIBN | Chief Executive Officer | Form 4 sale | 4,777 | $97k | 1.4% | Plan not stated | SEC |
| Nov 16, 2021 | SIBN | Chief Executive Officer | Form 4 sale | 4,849 | $104k | 2.2% | Plan not stated | SEC |
| Aug 16, 2021 | SIBN | Chief Executive Officer | Form 4 sale | 4,849 | $99k | 2.2% | Plan not stated | SEC |
| Jun 24, 2021 | Shockwave Medical, Inc. | Director | Form 4 sale | 1,500 | $300k | 100.0% | Unusual | SEC |
| Jun 14, 2021 | Shockwave Medical, Inc. | Director | Form 4 sale | 2,700 | $502k | 100.0% | Unusual | SEC |
| May 17, 2021 | SIBN | Chief Financial Officer | Form 4 sale | 5,242 | $165k | 2.5% | Plan not stated | SEC |
| Mar 18, 2021 | SIBN | Chief Financial Officer | Form 4 sale | 18,358 | $612k | 9.3% | Unusual | SEC |
| Mar 1, 2021 | SIBN | Chief Financial Officer | Form 4 sale | 400 | $13k | 0.2% | Plan not stated | SEC |
| Feb 16, 2021 | SIBN | Chief Financial Officer | Form 4 sale | 1,603 | $50k | 0.9% | Plan not stated | SEC |
| Feb 8, 2021 | SIBN | Chief Financial Officer | Form 4 sale | 10,642 | $352k | 5.6% | Plan not stated | SEC |
| Jan 26, 2021 | SIBN | Chief Financial Officer | Form 4 sale | 600 | $20k | 0.3% | Plan not stated | SEC |
| Nov 16, 2020 | SIBN | Chief Financial Officer | Form 4 sale | 3,925 | $93k | 2.9% | Plan not stated | SEC |
| Sep 14, 2020 | SIBN | Chief Financial Officer | Form 4 sale | 2,547 | $59k | 1.8% | Plan not stated | SEC |
| Aug 18, 2020 | SIBN | Chief Financial Officer | Form 4 sale | 21,029 | $442k | 13.5% | Unusual | SEC |
| Aug 10, 2020 | SIBN | Chief Financial Officer | Form 4 sale | 4,029 | $85k | 2.8% | Plan not stated | SEC |
| Aug 4, 2020 | SIBN | Chief Financial Officer | Form 4 sale | 4,931 | $95k | 3.4% | Plan not stated | SEC |
| Jun 19, 2020 | SIBN | Chief Financial Officer | Form 4 sale | 9,971 | $171k | 6.7% | Unusual | SEC |
| May 19, 2020 | SIBN | Chief Financial Officer | Form 4 sale | 4,267 | $72k | 3.0% | Plan not stated | SEC |
| Feb 19, 2020 | SIBN | Chief Financial Officer | Form 4 sale | 10,594 | $217k | 7.1% | Unusual | SEC |
| Dec 12, 2019 | SIBN | Chief Financial Officer | Form 4 sale | 9,796 | $187k | 10.2% | Unusual | SEC |
| Nov 18, 2019 | SIBN | Chief Financial Officer | Form 4 sale | 2,550 | $45k | 2.8% | Plan not stated | SEC |
| Jul 25, 2019 | SIBN | Chief Financial Officer | Form 4 sale | 2,518 | $49k | 2.7% | Plan not stated | SEC |
| Jul 18, 2019 | SIBN | Chief Financial Officer | Form 4 sale | 485 | $10k | 0.7% | Plan not stated | SEC |
| Jun 25, 2019 | SIBN | Chief Financial Officer | Form 4 sale | 2,518 | $45k | 3.4% | Plan not stated | SEC |
| May 28, 2019 | SIBN | Chief Financial Officer | Form 4 sale | 6,486 | $104k | 8.4% | Plan not stated | SEC |
| May 16, 2019 | SIBN | Chief Financial Officer | Form 4 sale | 2,000 | $32k | 2.8% | Plan not stated | SEC |
| Apr 26, 2018 | SIBN | Chief Financial Officer | Form 4 sale | 3,968 | $66k | 5.3% | Plan not stated | SEC |
| Apr 15, 2018 | SIBN | Chief Financial Officer | Form 4 sale | 3,012 | $51k | 4.1% | Plan not stated | SEC |